The market is convinced that a US rate hike is coming, but the new Chair Kevin Warsh seems reluctant. Previous Post Tata Sons Listing: HSBC lists four scenarios where Tata Chemicals can create up to 210% equity value Next Post Piramal Pharma shares fall 3% after USFDA issues 7 observations at UK facility Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
